Twist Bioscience
TWST
194 hedge funds and large institutions have $1.34B invested in Twist Bioscience in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 65 reducing their positions, and 26 closing their positions.
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
1% more funds holding
Funds holding: 193 → 194 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $1.39B → $1.34B (-$50.2M)
4.46% less ownership
Funds ownership: 119.27% → 114.81% (-4.5%)
11% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 65
46% less call options, than puts
Call options by funds: $2.86M | Put options by funds: $5.25M
Top Buyers
| 1 |
Millennium Management
New York
|
+$28.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$17.1M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$13M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.36M |
| 5 |
Two Sigma Investments
New York
|
+$5.18M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$18.6M |
| 2 |
BlackRock
New York
|
-$18.1M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
-$16.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$15M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10M |
TWST Hedge Fund Activity: Q3 2023 in Review
194 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2023, worth a combined $1.34B — down 3.6% from $1.39B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TWST positions and 26 closed out — a net gain of 2 holders — while 58 added to existing stakes and 65 trimmed.
The largest buyer was Millennium Management, adding an estimated $28.9M. The largest seller was State Street, cutting an estimated $18.6M.
- 194 institutional investors held Twist Bioscience (TWST) as of Q3 2023, up from 193 in Q2 2023.
- Funds reported $1.34B of Twist Bioscience stock for Q3 2023, down 3.6% quarter-over-quarter.
- 28 funds opened new Twist Bioscience positions in Q3 2023 and 26 closed out, a net change of +2 holders.
- The largest Twist Bioscience buyer in Q3 2023 was Millennium Management, an estimated $28.9M added.
- The largest Twist Bioscience seller in Q3 2023 was State Street, an estimated $18.6M sold.
Based on aggregated 13F filings for Q3 2023.